Cesar Sommer

4.1k total citations · 1 hit paper
39 papers, 3.0k citations indexed

About

Cesar Sommer is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Cesar Sommer has authored 39 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 18 papers in Oncology and 6 papers in Genetics. Recurrent topics in Cesar Sommer's work include CAR-T cell therapy research (16 papers), Pluripotent Stem Cells Research (12 papers) and CRISPR and Genetic Engineering (11 papers). Cesar Sommer is often cited by papers focused on CAR-T cell therapy research (16 papers), Pluripotent Stem Cells Research (12 papers) and CRISPR and Genetic Engineering (11 papers). Cesar Sommer collaborates with scholars based in United States, Brazil and United Kingdom. Cesar Sommer's co-authors include Gustavo Mostoslavsky, Darrell N. Kotton, George J. Murphy, Konrad Hochedlinger, Matthias Stadtfeld, Anjana Rao, Yun Huang, Stuart H. Orkin, George Q. Daley and Mamta Tahiliani and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Cesar Sommer

38 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tet1 and Tet2 Regulate 5-Hydroxymethylcytosine Production and Cell Lineage Specification in Mouse Embryonic Stem Cells

2011 608 citations Kian Peng Koh, Akiko Yabuuchi et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cesar Sommer United States	20	2.3k	457	425	422	314	39	3.0k
Wataru Ebina United States	9	2.6k 1.1×	446 1.0×	355 0.8×	509 1.2×	114 0.4×	12	3.0k
Guibin Chen United States	17	1.6k 0.7×	264 0.6×	397 0.9×	337 0.8×	236 0.8×	30	2.3k
Ruth K. Foreman United States	13	4.3k 1.8×	624 1.4×	555 1.3×	726 1.7×	270 0.9×	48	4.7k
Michael J. Edel Spain	20	1.8k 0.8×	245 0.5×	252 0.6×	313 0.7×	249 0.8×	52	2.4k
Jizhong Zou United States	25	2.3k 1.0×	469 1.0×	247 0.6×	210 0.5×	260 0.8×	77	2.8k
Akiko Yabuuchi United States	28	3.9k 1.7×	608 1.3×	388 0.9×	625 1.5×	229 0.7×	55	5.0k
Jonathan S. Draper Canada	21	3.8k 1.6×	588 1.3×	720 1.7×	824 2.0×	278 0.9×	31	4.4k
Elias T. Zambidis United States	29	2.2k 1.0×	213 0.5×	382 0.9×	444 1.1×	294 0.9×	61	3.3k
Hyenjong Hong United States	7	3.7k 1.6×	464 1.0×	511 1.2×	654 1.5×	326 1.0×	11	4.1k
Luigi Warren United States	8	2.3k 1.0×	330 0.7×	450 1.1×	372 0.9×	89 0.3×	10	2.6k

Countries citing papers authored by Cesar Sommer

Since Specialization

Citations

This map shows the geographic impact of Cesar Sommer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cesar Sommer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cesar Sommer more than expected).

Fields of papers citing papers by Cesar Sommer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cesar Sommer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cesar Sommer. The network helps show where Cesar Sommer may publish in the future.

Co-authorship network of co-authors of Cesar Sommer

This figure shows the co-authorship network connecting the top 25 collaborators of Cesar Sommer. A scholar is included among the top collaborators of Cesar Sommer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cesar Sommer. Cesar Sommer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Regina, Janette Sutton, Trevor Bentley, et al.. (2023). Constitutive Turbodomains enhance expansion and antitumor activity of allogeneic BCMA CAR T cells in preclinical models. Science Advances. 9(31). eadg8694–eadg8694. 3 indexed citations

Metelo, Ana M., Agnieszka Jóźwik, Le Anh Luong, et al.. (2022). Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors. Cancer Research Communications. 2(3). 158–171. 17 indexed citations

Sommer, Cesar, Hsin‐Yuan Cheng, Duy Nguyen, et al.. (2020). Allogeneic FLT3 CAR T Cells with an Off-Switch Exhibit Potent Activity against AML and Can Be Depleted to Expedite Bone Marrow Recovery. Molecular Therapy. 28(10). 2237–2251. 70 indexed citations

Sommer, Cesar, Regina Lin, Janette Sutton, et al.. (2020). Preclinical Evaluation of ALLO-605, an Allogeneic BCMA Turbocar TTM Cell Therapy for the Treatment of Multiple Myeloma. Blood. 136(Supplement 1). 8–8. 8 indexed citations

Sommer, Cesar, Trevor Bentley, Janette Sutton, et al.. (2019). Off-the-shelf AlloCAR T™ cells targeting BCMA for the treatment of multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 19(10). e24–e24. 3 indexed citations

Sommer, Cesar, Amalia Capilla, Nicholas Skvir, et al.. (2018). Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells. PLoS ONE. 13(7). e0200657–e0200657. 28 indexed citations

Valton, Julien, Valérie Guyot, Bijan Boldajipour, et al.. (2018). A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies. Scientific Reports. 8(1). 8972–8972. 28 indexed citations

Djuretic, Ivana M., Veena Krishnamoorthy, Cesar Sommer, et al.. (2018). A Novel Full Length Anti-FLT3 CD3 Bispecific Antibody for the Treatment of Acute Myeloid Leukemia. Blood. 132(Supplement 1). 1445–1445. 1 indexed citations

Kitano, Kentaro, Haiyang Zhou, Sarah E. Gilpin, et al.. (2017). Bioengineering of functional human induced pluripotent stem cell-derived intestinal grafts. Nature Communications. 8(1). 765–765. 83 indexed citations

10.

Etchegaray, Jean‐Pierre, Lukas Chávez, Yun Huang, et al.. (2015). The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine. Nature Cell Biology. 17(5). 545–557. 125 indexed citations

11.

Fragola, Giulia, Pierre‐Luc Germain, Pasquale Laise, et al.. (2013). Cell Reprogramming Requires Silencing of a Core Subset of Polycomb Targets. PLoS Genetics. 9(2). e1003292–e1003292. 55 indexed citations

12.

Sommer, Cesar & Gustavo Mostoslavsky. (2012). The evolving field of induced pluripotency: Recent progress and future challenges. Journal of Cellular Physiology. 228(2). 267–275. 35 indexed citations

13.

Sommer, Cesar, Constantina Christodoulou, Steven S. Shen, et al.. (2012). Residual Expression of Reprogramming Factors Affects the Transcriptional Program and Epigenetic Signatures of Induced Pluripotent Stem Cells. PLoS ONE. 7(12). e51711–e51711. 39 indexed citations

14.

Christodoulou, Constantina, Tyler A. Longmire, Steven S. Shen, et al.. (2011). Mouse ES and iPS cells can form similar definitive endoderm despite differences in imprinted genes. Journal of Clinical Investigation. 121(6). 2313–2325. 39 indexed citations

15.

Koh, Kian Peng, Akiko Yabuuchi, Sridhar Rao, et al.. (2011). Tet1 and Tet2 Regulate 5-Hydroxymethylcytosine Production and Cell Lineage Specification in Mouse Embryonic Stem Cells. Cell stem cell. 8(2). 200–213. 608 indexed citations breakdown →

16.

Ye, Jinhai, Yuanjin Xu, Jun Gao, et al.. (2011). Critical-size calvarial bone defects healing in a mouse model with silk scaffolds and SATB2-modified iPSCs. Biomaterials. 32(22). 5065–5076. 134 indexed citations

17.

Sommer, Cesar & Gustavo Mostoslavsky. (2010). Experimental approaches for the generation of induced pluripotent stem cells. Stem Cell Research & Therapy. 1(3). 26–26. 27 indexed citations

18.

Duan, Xuejing, Qisheng Tu, Jin Zhang, et al.. (2010). Application of induced pluripotent stem (iPS) cells in periodontal tissue regeneration. Journal of Cellular Physiology. 226(1). 150–157. 145 indexed citations

19.

Sommer, Cesar, Andrea Soares‐Costa, Patrícia A. Possik, et al.. (2005). Gene expression profile of human Down syndrome leukocytes.. PubMed. 46(4). 647–56. 13 indexed citations

20.

Sommer, Cesar, et al.. (2005). Expression, purification, and structural analysis of UBE2G2 (human ubiquitin-conjugating enzyme). Protein Expression and Purification. 45(2). 324–328. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact